当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析 - 现金流量表

百洋医药

(301015)

  

流通市值:138.01亿  总市值:138.03亿
流通股本:5.26亿   总股本:5.26亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,304,553,603.474,328,271,152.392,087,852,699.038,697,122,792.15
  收到的税费返还---15,199.93
  收到其他与经营活动有关的现金116,424,960.392,090,949.8218,877,112.8667,012,976.6
  经营活动现金流入小计6,420,978,563.774,420,362,102.212,106,729,811.898,764,150,968.68
  购买商品、接受劳务支付的现金3,771,991,577.062,692,725,011.331,235,305,068.115,406,665,968.67
  支付给职工以及为职工支付的现金551,404,350.07366,869,782.7209,115,398.56669,705,715.34
  支付的各项税费451,986,423.21323,491,104.13121,183,886.88632,988,222.72
  支付其他与经营活动有关的现金1,024,178,648.22645,511,546.65241,134,774.251,240,940,657.06
  经营活动现金流出小计5,799,560,998.564,028,597,444.811,806,739,127.87,950,300,563.79
  经营活动产生的现金流量净额621,417,565.21391,764,657.4299,990,684.09813,850,404.89
二、投资活动产生的现金流量:
  收回投资收到的现金230,000,000130,000,00050,000,000385,763,665.81
  取得投资收益收到的现金6,771,532.946,040,308.44151,288.527,676,310.04
  处置固定资产、无形资产和其他长期资产收回的现金净额29,134.429,134.42,000789,550
  处置子公司及其他营业单位收到的现金净额---4,431,256.6
  投资活动现金流入小计236,800,667.34136,069,442.8450,153,288.52398,660,782.45
  购建固定资产、无形资产和其他长期资产支付的现金198,271,915.1290,772,573.2226,012,575.92303,988,622.66
  投资支付的现金568,098,746.96326,000,000226,000,000823,596,361.32
  取得子公司及其他营业单位支付的现金---3,394,522.38
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计766,370,662.08416,772,573.22252,012,575.921,130,979,506.36
  投资活动产生的现金流量净额-529,569,994.74-280,703,130.38-201,859,287.4-732,318,723.91
三、筹资活动产生的现金流量:
  吸收投资收到的现金980,000980,000980,000980,000
  其中:子公司吸收少数股东投资收到的现金980,000980,000980,000980,000
  取得借款收到的现金2,002,726,449.91,838,701,348.45628,675,025.761,971,450,088.93
  收到其他与筹资活动有关的现金231,979,024.82307,000,919.4781,730,359.73227,363,162.02
  筹资活动现金流入小计2,235,685,474.722,146,682,267.92711,385,385.492,199,793,250.95
  偿还债务支付的现金1,136,468,352.05954,064,439.1427,114,735.28918,161,858.87
  分配股利、利润或偿付利息支付的现金469,123,784.76439,251,640.7713,810,555.75465,579,088.96
  其中:子公司支付给少数股东的股利、利润18,539,459.656,400,000-15,716,833.52
  支付其他与筹资活动有关的现金287,221,716.98276,041,706.775,219,426.83811,386,636.15
  筹资活动现金流出小计1,892,813,853.791,669,357,786.64446,144,717.862,195,127,583.98
  筹资活动产生的现金流量净额342,871,620.93477,324,481.28265,240,667.634,665,666.97
四、汇率变动对现金及现金等价物的影响-6,340,154.17-3,208,683.17-1,701,430.832,205,432.12
五、现金及现金等价物净增加额428,379,037.23585,177,325.13361,670,633.4988,402,780.07
  加:期初现金及现金等价物余额1,222,546,194.051,222,546,194.051,222,546,194.051,134,143,413.98
  期末现金及现金等价物余额1,650,925,231.281,807,723,519.181,584,216,827.541,222,546,194.05
补充资料:
  净利润-211,406,109.96-767,030,644.39
  资产减值准备-38,005,850.23-27,850,969.68
  固定资产和投资性房地产折旧-30,266,722.72-46,292,654.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-30,266,722.72-46,292,654.26
  无形资产摊销-11,268,396.99-16,601,383.91
  长期待摊费用摊销-2,793,638.25-6,196,597.82
  处置固定资产、无形资产和其他长期资产的损失--1,800--925,017.58
  固定资产报废损失-166,348.3-456,559.16
  公允价值变动损失-25,747,207.09--1,715,871.08
  财务费用-51,450,082.98-79,926,105.99
  投资损失-15,444,667.73--63,438,087.02
  递延所得税--37,798,741.72-3,320,040.05
  其中:递延所得税资产减少--26,040,584.05-18,475,828.37
    递延所得税负债增加--11,758,157.67--15,155,788.32
  存货的减少-123,054,118.11--70,231,498.94
  经营性应收项目的减少-198,390,721.59--85,140,766.88
  经营性应付项目的增加--292,953,899.67-64,502,977.6
  现金的期末余额-1,798,099,280.48-1,212,445,674.09
  减:现金的期初余额-1,212,445,674.09-1,128,096,282.67
  加:现金等价物的期末余额-9,624,238.7-10,100,519.96
  减:现金等价物的期初余额-10,100,519.96-6,047,131.31
  现金及现金等价物的净增加额-585,177,325.13-88,402,780.07
公告日期2025-10-302025-08-292025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑